Cargando…
Aldehyde dehydrogenase 2 is associated with cognitive functions in patients with Parkinson’s disease
Neurotransmitter degradation has been proposed to cause the accumulation of neurotoxic metabolites. The metabolism of these metabolites involves aldehyde dehydrogenase 2 (ALDH2). The Asian-specific single nucleotide polymorphism rs671 causes reduced enzyme activity. This study aims to explore whethe...
Autores principales: | Yu, Rwei-Ling, Tan, Chun-Hsiang, Lu, Ying-Che, Wu, Ruey-Meei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958972/ https://www.ncbi.nlm.nih.gov/pubmed/27453488 http://dx.doi.org/10.1038/srep30424 |
Ejemplares similares
-
The impact of nocturnal disturbances on daily quality of life in patients with Parkinson’s disease
por: Yu, Rwei-Ling, et al.
Publicado: (2015) -
Mild cognitive impairment in patients with Parkinson’s disease: An updated mini-review and future outlook
por: Yu, Rwei-Ling, et al.
Publicado: (2022) -
Effect of ALDH2 on Sleep Disturbances in Patients with Parkinson’s Disease
por: Lin, Chia-Yen, et al.
Publicado: (2019) -
Interactions of COMT and ALDH2 Genetic Polymorphisms on Symptoms of Parkinson’s Disease
por: Yu, Rwei-Ling, et al.
Publicado: (2021) -
Social brain dysfunctions in patients with Parkinson’s disease: a review of theory of mind studies
por: Yu, Rwei-Ling, et al.
Publicado: (2013)